Us Pharmaceutical Market News - Latest Updates & Headlines
Celltrion launches autoimmune disease treatment in US
Seoul, March 13: Celltrion, a major South Korean biopharmaceutical firm, on Thursday said it has launched its biosimilar product for Stelara, an autoimmune disease treatment, in the United States.